WARRANTS - Narrative (Details) $ / shares in Units, $ in Thousands								3 Months Ended		6 Months Ended
	Jul. 31, 2023	Jul. 14, 2023	Jun. 14, 2023 USD ($)	Mar. 13, 2023 USD ($) $ / shares shares	Mar. 09, 2023 USD ($) $ / shares shares	Jul. 01, 2022 USD ($) $ / shares shares	Apr. 04, 2022 USD ($) $ / shares shares	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 16, 2023 $ / shares shares	Feb. 10, 2023 USD ($) $ / shares shares	Mar. 30, 2022 closing $ / shares shares
Class of Warrant or Right [Line Items]
Stock split, conversion ratio			0.0200
Proceeds from issuance of warrants in private placement										$ 15,999	$ 37,201
Gain (loss) on issuance of warrants				$ (10,424)				$ 0	$ 0	(10,424)	$ 0
Private Placement
Class of Warrant or Right [Line Items]
Number of shares authorized to be sold (in shares) \| shares														942,000
Number of shares called by warrants (in shares) \| shares														470,000
Number of closings \| closing														2
Sale of stock (in USD per share) \| $ / shares														$ 50.13
Proceeds from issuance of warrants in private placement					$ 16,000
Warrants Issued April 2022 \| Private Placement
Class of Warrant or Right [Line Items]
Number of shares called by warrants (in shares) \| shares							376,000
Number of shares sold or expected to be sold (in shares) \| shares							75,200
Gross proceeds from private placement							$ 40,000
Fair value							$ 9,200
Term of warrants (in years)							5 years
Exercise price of warrants issued (in USD per share) \| $ / shares							$ 62.50
Warrants Issued July 2022 \| Private Placement
Class of Warrant or Right [Line Items]
Number of shares called by warrants (in shares) \| shares						94,000
Number of shares sold or expected to be sold (in shares) \| shares						188,000
Gross proceeds from private placement						$ 10,000
Fair value						$ 4,500
Term of warrants (in years)						5 years
Exercise price of warrants issued (in USD per share) \| $ / shares						$ 62.50
SVB Warrants
Class of Warrant or Right [Line Items]
Number of shares called by warrants (in shares) \| shares												5,400	4,000
Fair value													$ 57
Exercise price of warrants issued (in USD per share) \| $ / shares												$ 10.25	$ 16.37
Pre-Funded Warrant Liability
Class of Warrant or Right [Line Items]
Number of shares called by warrants (in shares) \| shares					996,300
Fair value			$ 14,900	$ 15,900
Exercise price of warrants issued (in USD per share) \| $ / shares					$ 0.05
Stock exercise price (in USD per share) \| $ / shares					$ 16.06
Proceeds from issuance of warrants in private placement					$ 16,000
Percentage of common stock outstanding prior to offering					19.99%
Gain (loss) on issuance of warrants								(900)		(900)
Pre-Funded Warrant Liability \| Private Placement
Class of Warrant or Right [Line Items]
Number of shares called by warrants (in shares) \| shares				49,813,198
Exercise price of warrants issued (in USD per share) \| $ / shares				$ 0.001
Series-A Warrant Liability
Class of Warrant or Right [Line Items]
Number of shares called by warrants (in shares) \| shares					996,300
Fair value			$ 9,300	$ 10,500
Exercise price of warrants issued (in USD per share) \| $ / shares					$ 19.27
Gain (loss) on issuance of warrants								$ 2,100		$ 2,100
Series-A Warrant Liability \| Private Placement
Class of Warrant or Right [Line Items]
Number of shares called by warrants (in shares) \| shares												49,813,198
Exercise price of warrants issued (in USD per share) \| $ / shares												$ 0.38544
Subsequent Event
Class of Warrant or Right [Line Items]
Stock split, conversion ratio	0.0200	0.0200

MedAvail Holdings, Inc. 10-Q